An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-04-16
DOI
10.1038/s41467-021-22465-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Marker lesion study of oral FGFR inhibitor BGJ398 in patients with FGFR3-altered intermediate-risk nonmuscle-invasive bladder cancer.
- (2020) Eugene K. Cha et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Differential Tumor Subtypes of T1 Bladder Cancer
- (2020) A. Gordon Robertson et al. EUROPEAN UROLOGY
- Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
- (2020) Ann Taber et al. Nature Communications
- Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
- (2019) Yuna Blum et al. Nature Communications
- Neoantigen-directed immune escape in lung cancer evolution
- (2019) Rachel Rosenthal et al. NATURE
- Molecular pathology of the luminal class of urothelial tumors
- (2019) Carina Bernardo et al. JOURNAL OF PATHOLOGY
- RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues
- (2019) Keren Yizhak et al. SCIENCE
- Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
- (2019) Brian D. Robinson et al. Nature Communications
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update
- (2019) Marko Babjuk et al. EUROPEAN UROLOGY
- A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
- (2019) Aurélie Kamoun et al. EUROPEAN UROLOGY
- Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG Unresponsive Trials
- (2019) Max Kates et al. CLINICAL CANCER RESEARCH
- Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma
- (2019) Gottfrid Sjödahl et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of an immunotherapy-responsive molecular subtype of bladder cancer
- (2019) Bic-Na Song et al. EBioMedicine
- Molecular Markers Increase Precision of the European Association of Urology Non–Muscle-Invasive Bladder Cancer Progression Risk Groups
- (2018) Kim E.M. van Kessel et al. CLINICAL CANCER RESEARCH
- Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review
- (2018) Ashish M. Kamat et al. EUROPEAN UROLOGY
- A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort
- (2018) Nour-al-dain Marzouka et al. Scientific Reports
- Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness
- (2018) Malin E. Winerdal et al. Cancer Immunology Research
- Biology of nonmuscle-invasive bladder cancer
- (2018) Lars Dyrskjøt et al. CURRENT OPINION IN UROLOGY
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens
- (2018) Ryosuke Murai et al. PLoS One
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
- (2017) Marko Babjuk et al. EUROPEAN UROLOGY
- Prognostic Impact of a 12-gene Progression Score in Non–muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study
- (2017) Lars Dyrskjøt et al. EUROPEAN UROLOGY
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
- (2017) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- Fully automated 5-plex fluorescent immunohistochemistry with tyramide signal amplification and same species antibodies
- (2017) Wenjun Zhang et al. LABORATORY INVESTIGATION
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
- (2017) Teresa Davoli et al. SCIENCE
- Gene expression markers of Tumor Infiltrating Leukocytes
- (2017) Patrick Danaher et al. Journal for ImmunoTherapy of Cancer
- Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
- (2016) Jakob Hedegaard et al. CANCER CELL
- Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma
- (2016) Philippe Lamy et al. CANCER RESEARCH
- Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
- (2016) Jakub Dobruch et al. EUROPEAN UROLOGY
- Safety, clinical activity, and PD-L1 expression of avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with metastatic urothelial carcinoma from the JAVELIN Solid Tumor phase Ib trial.
- (2016) Andrea B. Apolo et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
- (2016) Jaegil Kim et al. NATURE GENETICS
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer
- (2016) R. F. Sweis et al. Cancer Immunology Research
- A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma
- (2015) Oliver Patschan et al. EUROPEAN UROLOGY
- Regulators of genetic risk of breast cancer identified by integrative network analysis
- (2015) Mauro A A Castro et al. NATURE GENETICS
- The prognostic effect of tumour-infiltrating lymphocytic subpopulations in bladder cancer
- (2015) T. Horn et al. WORLD JOURNAL OF UROLOGY
- APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
- (2015) C. Swanton et al. Cancer Discovery
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease
- (2014) Robert S. Svatek et al. EUROPEAN UROLOGY
- Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology
- (2014) J. S. Damrauer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- EGFR as a potential therapeutic target for a subset of muscle-invasive bladder cancers presenting a basal-like phenotype
- (2014) S. Rebouissou et al. Science Translational Medicine
- Chemoprevention of BBN-Induced Bladder Carcinogenesis by the Selective Estrogen Receptor Modulator Tamoxifen
- (2014) Suraj Konnath George et al. Translational Oncology
- Independent Component Analysis Uncovers the Landscape of the Bladder Tumor Transcriptome and Reveals Insights into Luminal and Basal Subtypes
- (2014) Anne Biton et al. Cell Reports
- Elevated APOBEC3B Correlates with Poor Outcomes for Estrogen-Receptor-Positive Breast Cancers
- (2014) Anieta M. Sieuwerts et al. Hormones & Cancer
- Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor
- (2013) Jong-Wei Hsu et al. AMERICAN JOURNAL OF PATHOLOGY
- Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development
- (2013) Iawen Hsu et al. CARCINOGENESIS
- High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer
- (2013) Cherifa Ayari et al. HUMAN PATHOLOGY
- Signatures of mutational processes in human cancer
- (2013) Ludmil B. Alexandrov et al. NATURE
- Analysis of molecular intra-patient variation and delineation of a prognostic 12-gene signature in non-muscle invasive bladder cancer; technology transfer from microarrays to PCR
- (2012) L Dyrskjøt et al. BRITISH JOURNAL OF CANCER
- Novel Tumor Subgroups of Urothelial Carcinoma of the Bladder Defined by Integrated Genomic Analysis
- (2012) C. D. Hurst et al. CLINICAL CANCER RESEARCH
- A Molecular Taxonomy for Urothelial Carcinoma
- (2012) G. Sjodahl et al. CLINICAL CANCER RESEARCH
- Cancer chromosomal instability: therapeutic and diagnostic challenges
- (2012) Nicholas McGranahan et al. EMBO REPORTS
- Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
- (2012) Ashish M. Kamat et al. JOURNAL OF UROLOGY
- Epithelial Plasticity, Cancer Stem Cells, and the Tumor-Supportive Stroma in Bladder Carcinoma
- (2012) G. van der Horst et al. MOLECULAR CANCER RESEARCH
- A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage response
- (2012) T Schepeler et al. ONCOGENE
- Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma
- (2012) David Lindgren et al. PLoS One
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
- (2010) Matthew D. Wilkerson et al. BIOINFORMATICS
- Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
- (2010) Wun-Jae Kim et al. Molecular Cancer
- Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis
- (2008) Kasper Thorsen et al. MOLECULAR & CELLULAR PROTEOMICS
- An Oncogene-Induced DNA Damage Model for Cancer Development
- (2008) T. D. Halazonetis et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search